Observing Defense: Stocks may be subject to other risk warnings.
West Point Pharmaceuticals shareholders Guotou High-Tech and Hangzhou Chuanghe plan to collectively reduce their holdings by no more than 3%; Zhejiang Talent Television and Film shareholder Dongyang Juwen plans to reduce their holdings by no more than 2%; Hualv Biotechnology shareholder Gaotou Development plans to reduce their holdings by no more than 5.36%; Haoyuan Medicine shareholders Suxin Fund and Zhenjin Investment plan to collectively reduce their holdings by no more than 3.34%; Zhengzhou Tiamaes Technology incurred a net loss of 52.8719 million yuan in the first three quarters; Guandian Defense stocks may be subject to other risk warnings; China Design Group stated that director Liu Peng received a notice of filing.
